Metabotropic glutamate receptor 5 in Down's syndrome hippocampus during development: Increased expression in astrocytes

Current Alzheimer Research

Volumn 11, Issue 7, 2014, Pages 694-705

  Iyer, A M ^a   van Scheppingen, J ^a   Milenkovic, I ^b   Anink, J J ^a   Lim, D ^c   Genazzani, A A ^c   Adle Biassette, H ^d   Kovacs, G G ^b   Aronica, E ^a,e,f  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d HÔPITAL ROBERT DEBRÉ   (France)

^e STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Alzheimer's disease; Astrocytes; Development; Down's syndrome; Hippocampus; MGluR5

Indexed keywords

AMYLOID BETA PROTEIN; METABOTROPIC RECEPTOR 5; GRM5 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; ASTROCYTE; BRAIN DEVELOPMENT; CELL CULTURE; CHILD; CONTROLLED STUDY; DOWN SYNDROME; FETUS; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; NERVE DEGENERATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBVENTRICULAR ZONE; WESTERN BLOTTING; WHITE MATTER; FEMALE; GESTATIONAL AGE; GROWTH, DEVELOPMENT AND AGING; MALE; METABOLISM; MIDDLE AGED; NERVE CELL; NEWBORN; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; ALVEUS; AUTOPSY; DENTATE GYRUS; IN VITRO STUDY; NEUROFIBRILLARY TANGLE; STRATUM PYRAMIDALE;

ADOLESCENT; ALZHEIMER DISEASE; ASTROCYTES; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HIPPOCAMPUS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEURONS; PLAQUE, AMYLOID; RECEPTOR, METABOTROPIC GLUTAMATE 5; WHITE MATTER;

EID: 84906919024     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205011666140812115423     Document Type: Article

References (58)

1. Pin JP, Acher F. The metabotropic glutamate receptors: structure, activation mechanism and pharmacology. Cur Drug Targets Cns Neurol Dis 1(3): 297-317 (2002).
2. Mukherjee S, Manahan-Vaughan D. Role of metabotropic glutamate receptors in persistent forms of hippocampal plasticity and learning. Neuropharmacology 66: 65-81 (2013).
3. Conn PJ. Physiological roles and therapeutic potential of metabotropic glutamate receptors. Ann N Y Acad Sci 1003: 12-21 (2003).
4. Niswender CM, Conn PJ. Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol 50: 295-322 (2010).
5. Aronica E, Gorter JA, Ijlst-Keizers H, Rozemuller AJ, Yankaya B, Leenstra S, et al. Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins. Eur J Neurosci 17(10): 2106-18 (2003).
6. D'Antoni S, Berretta A, Bonaccorso CM, Bruno V, Aronica E, Nicoletti F, et al. Metabotropic glutamate receptors in glial cells. Neurochem Res 33(12): 2436-43 (2008).
7. Caraci F, Battaglia G, Sortino MA, Spampinato S, Molinaro G, Copani A, et al. Metabotropic glutamate receptors in neurodegeneration/neuroprotection: still a hot topic? Neurochem Int 61(4): 559-65 (2012).
8. Bradley SJ, Challiss RA. G protein-coupled receptor signalling in astrocytes in health and disease: a focus on metabotropic glutamate receptors. Biochem Pharmacol 84(3): 249-59 (2012).
9. Di Giorgi Gerevini VD, Caruso A, Cappuccio I, Ricci Vitiani L, Romeo S, Della Rocca C, et al. The mGlu5 metabotropic glutamate receptor is expressed in zones of active neurogenesis of the embryonic and postnatal brain. Brain Res Dev Brain Res 150(1): 17-22 (2004).
10. Di Giorgi-Gerevini V, Melchiorri D, Battaglia G, Ricci-Vitiani L, Ciceroni C, Busceti CL, et al. Endogenous activation of metabotropic glutamate receptors supports the proliferation and survival of neural progenitor cells. Cell Death & Differentiation 12(8): 1124-33 (2005).
11. Schlett K. Glutamate as a modulator of embryonic and adult neurogenesis. Curr Top Med Chem 6(10): 949-60 (2006).
12. Catania MV, D'Antoni S, Bonaccorso CM, Aronica E, Bear MF, Nicoletti F. Group I metabotropic glutamate receptors: a role in neurodevelopmental disorders? Mol Neurobiol 35(3): 298-307 (2007).
13. Catania MV, Landwehrmeyer GB, Testa CM, Standaert DG, Penney JB, Jr., Young AB. Metabotropic glutamate receptors are differentially regulated during development. Neuroscience 61(3): 481-95 (1994).
14. Minakami R, Iida K, Hirakawa N, Sugiyama H. The expression of two splice variants of metabotropic glutamate receptor subtype 5 in the rat brain and neuronal cells during development. J Neurochem 65(4): 1536-42.(1995).
15. Romano C, van den Pol AN, O'Malley KL. Enhanced early developmental expression of the metabotropic glutamate receptor mGluR5 in rat brain: protein, mRNA splice variants, and regional distribution. J Comparative Neurol 367(3): 403-12 (1996).
16. Boer K, Encha-Razavi F, Sinico M, Aronica E. Differential distribution of group I metabotropic glutamate receptors in developing human cortex. Brain Res 1324: 24-33 (2010).
17. Yang P, Zhang J, Zhao L, Jiao Q, Jin H, Xiao X, et al. Developmental distribution pattern of metabotropic glutamate receptor 5 in prenatal human hippocampus. Neurosci Bull 28(6): 704-14 (2012).
18. Piers TM, Kim DH, Kim BC, Regan P, Whitcomb DJ, Cho K. Translational Concepts of mGluR5 in Synaptic Diseases of the Brain. Front Pharmacol 3: 199 (2012).
19. Gravius A, Pietraszek M, Dekundy A, Danysz W. Metabotropic glutamate receptors as therapeutic targets for cognitive disorders. Curr Top Med Chem 10(2): 187-206 (2010).
20. Menard C, Quirion R. Group 1 metabotropic glutamate receptor function and its regulation of learning and memory in the aging brain. Front Pharmacol 3: 182 (2012).
21. Roselli F. Down syndrome DSCR1 causes spine pathology via the Fragile X-related protein FMRP. Embo J 31(18): 3647-9 (2012).
22. Cork LC. Neuropathology of Down syndrome and Alzheimer disease. Am J Med Genet Suppl 7: 282-6 (1990).
23. Contestabile A, Benfenati F, Gasparini L. Communication breaksDown: from neurodevelopment defects to cognitive disabilities in Down syndrome. Prog Neurobiol 91(1): 1-22 (2010).
24. Garner CC, Wetmore DZ. Synaptic pathology of Down syndrome. Adv Exp Med Biol 970: 451-68 (2012).
25. Lee RK, Wurtman RJ, Cox AJ, Nitsch RM. Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors. Proc Natl Acad Sci USA 92(17): 8083-7 (1995).
26. Westmark CJ, Malter JS. FMRP mediates mGluR5-dependent translation of amyloid precursor protein. PLoS Biol 5(3): e52 (2007).
27. Malter JS, Ray BC, Westmark PR, Westmark CJ. Fragile X Syndrome and Alzheimer's Disease: Another story about APP and beta-amyloid. Curr Alzheimer Res 7(3): 200-6 (2010).
28. Casley CS, Lakics V, Lee HG, Broad LM, Day TA, Cluett T, et al. Up-regulation of astrocyte metabotropic glutamate receptor 5 by amyloid-beta peptide. Brain Res 2009.
29. Lim D, Iyer A, Ronco V, Grolla AA, Canonico PL, Aronica E, et al. Amyloid beta deregulates astroglial mGluR5-mediated calcium signaling via calcineurin and Nf-kB. Glia 61(7): 1134-45 (2013).
30. Grolla AA, Fakhfouri G, Balzaretti G, Marcello E, Gardoni F, Canonico PL, et al. Abeta leads to Ca(2)(+) signaling alterations and transcriptional changes in glial cells. Neurobiol Aging 34(2): 511-22 (2013).
31. Oka A, Takashima S. The up-regulation of metabotropic glutamate receptor 5 (mGluR5) in Down's syndrome brains. Acta Neuropathol (Berl) 97(3): 275-8 (1999).
32. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112(4): 389-404 (2006).
33. Aronica E, Yankaya B, Jansen GH, Leenstra S, van Veelen CW, Gorter JA, et al. Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumors from patients with intractable epilepsy. Neuropathol Appl Neurobiol 27: 1-16 (2001).
34. Aronica E, Catania MV, Geurts J, Yankaya B, Troost D. Immunohistochemical localization of group I and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: upregulation in reactive astrocytes. Neuroscience 105(2): 509-20 (2001).
35. Aronica E, Gorter JA, Jansen GH, van Veelen CW, van Rijen PC, Ramkema M, et al. Expression and cell distribution of group I and group II metabotropic glutamate receptor subtypes in taylor-type focal cortical dysplasia. Epilepsia 44(6): 785-95 (2003).
36. Ravizza T, Boer K, Redeker S, Spliet WG, van Rijen PC, Troost D, et al. The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol Dis 24(1): 128-43 (2006).
37. Iyer A, Zurolo E, Spliet WGM, van Rijen PC, Baayen JC, Gorter JA, et al. Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias. Epilepsia 51(9): 1763-732010.
38. Aronica E, Gorter JA, Redeker S, Ramkema M, Spliet WG, van Rijen PC, et al. Distribution, characterization and clinical significance of microglia in glioneuronal tumours from patients with chronic intractable epilepsy. Neuropath App Neurobiol 31(3): 280-91 (2005).
39. Toering ST, Boer K, de Groot M, Troost D, Heimans JJ, Spliet WG, et al. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers. Epilepsia 50(6): 1409-18 (2009).
40. Aronica E, Gorter JA, Rozemuller AJ, Yankaya B, Troost D. Interleukin-1 beta down-regulates the expression of metabotropic glutamate receptor 5 in cultured human astrocytes. J Neuroimmunol 160(1-2): 188-94 (2005).
41. Shigemoto R, Nakanishi S, Mizuno N. Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: an in situ hybridization study in adult and developing rat. J Comp Neurol 322(1): 121-35 (1992).
42. Lopez-Bendito G, Shigemoto R, Fairen A, Lujan R. Differential distribution of group I metabotropic glutamate receptors during rat cortical development. Cereb Cortex 12(6): 625-38 (2002).
43. Cappuccio I, Spinsanti P, Porcellini A, Desiderati F, De Vita T, Storto M, et al. Endogenous activation of mGlu5 metabotropic glutamate receptors supports self-renewal of cultured mouse embryonic stem cells. Neuropharmacology 49(1): 196-205 (2005).
44. Spinsanti P, De Vita T, Di Castro S, Storto M, Formisano P, Nicoletti F, et al. Endogenously activated mGlu5 metabotropic glutamate receptors sustain the increase in c-Myc expression induced by leukaemia inhibitory factor in cultured mouse embryonic stem cells. J Neurochem 99(1): 299-307 (2006).
45. Castiglione M, Calafiore M, Costa L, Sortino MA, Nicoletti F, Copani A. Group I metabotropic glutamate receptors control proliferation, survival and differentiation of cultured neural progenitor cells isolated from the subventricular zone of adult mice. Neuropharmacology 55(4): 560-7 (2008).
46. Kawabata S, Kohara A, Tsutsumi R, Itahana H, Hayashibe S, Yamaguchi T, et al. Diversity of calcium signaling by metabotropic glutamate receptors. J BiolChem 273(28): 17381-5 (1998).
47. Mao L, Yang L, Tang Q, Samdani S, Zhang G, Wang JQ. The scaffold protein Homer1b/c links metabotropic glutamate receptor 5 to extracellular signal-regulated protein kinase cascades in neurons. J Neurosci 25(10): 2741-52 (2005).
48. O'Malley KL, Jong YJ, Gonchar Y, Burkhalter A, Romano C. Activation of metabotropic glutamate receptor mGlu5 on nuclear membranes mediates intranuclear Ca2+ changes in heterologous cell types and neurons. J Biol Chem 278(30): 28210-9 (2003).
49. Jong YJ, Kumar V, O'Malley KL. Intracellular metabotropic glutamate receptor 5 (mGluR5) activates signaling cascades distinct from cell surface counterparts. J Biol Chem 284(51): 35827-38 (2009).
50. Kanaumi T, Milenkovic I, Adle-Biassette H, Aronica E, G.G. K. Non-neuronal cell responses differ between normal and Down syndrome developing brains. Int J Developmental Neurosci 31(8):796-803in press).
51. D'Antoni S, Berretta A, Bonaccorso CM, Bruno V, Aronica E, Nicoletti F, et al. Metabotropic glutamate receptors in glial cells. Neurochem Res 33(12): 2436-43 (2008).
52. Ciccarelli R, Sureda FX, Casabona G, Di Iorio P, Caruso A, Spinella F, et al. Opposite influence of the metabotropic glutamate receptor subtypes mGlu3 and -5 on astrocyte proliferation in culture. Glia 21(4): 390-8 (1997).
53. Battaglia G, Bruno V, Ngomba RT, Di Grezia R, Copani A, Nicoletti F. Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death. Eur J Pharmacol 356(2-3): 271-4 (1998).
54. Ciccarelli R, Di Iorio P, Bruno V, Battaglia G, D'Alimonte I, D'Onofrio M, et al. Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes. Glia 27(3): 275-81 (1999).
55. Aronica E, Gorter JA, Rozemuller AJ, Yankaya B, Troost D. Activation of metabotropic glutamate receptor 3 enhances interleukin (IL)-1beta-stimulated release of IL-6 in cultured human astrocytes. Neuroscience 130(4): 927-33 (2005).
56. Gegelashvili G, Dehnes Y, Danbolt NC, Schousboe A. The highaffinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signalling mechanisms. Neurochem Int 37(2-3): 163-70 (2000).
57. Serge A, Fourgeaud L, Hemar A, Choquet D. Receptor activation and homer differentially control the lateral mobility of metabotropic glutamate receptor 5 in the neuronal membrane. J Neurosci 22(10): 3910-20 (2002).
58. Ronesi JA, Collins KA, Hays SA, Tsai NP, Guo W, Birnbaum SG, et al. Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome. Nat Neurosci 15(3): 431-40: S1 (2012).